DUOS TECHNOLOGIES GROUP, INC. current report, 31 July 2023

Business Context and Reporting Period

Company: Duos Technologies Group, Inc. (DUOT)
Filing Type: Form 8-K (Current Report)
Date of Report: July 31, 2023 (Event Date: August 1, 2023)
Context: The Company entered into a Securities Purchase Agreement with existing investors to raise capital through the issuance of Series F Convertible Preferred Stock.

Key Financial Metrics and Transaction Details

  • Capital Raised: $5,000,000 in aggregate proceeds.
  • Instrument: 5,000 shares of Series F Convertible Preferred Stock.
  • Price per Share: $1,000 stated value.
  • Conversion Price: $6.20 per share of common stock (subject to adjustments).
  • Revenue/Profit/Cash Flow: This filing does not provide revenue, profit, cash flow, margin, or debt metrics. It reports a specific financing event.

Material Changes and Terms

The Company amended its Certificate of Incorporation to authorize the Series F Preferred Stock. Key terms include:

  • Voting Rights: Each share carries 161 votes (subject to adjustment), voting together with common stock.
  • Dividends: No separate dividend; holders receive dividends on an as-converted-to-common basis.
  • Beneficial Ownership Limitation: Conversion is limited to prevent holders from owning more than 4.99% (or 19.99% if elected) of outstanding common stock. Purchasers elected the 19.99% limit.
  • Liquidation Preference: Participates on an as-converted-to-common basis with common stockholders.
  • Registration Rights: The Company must file a registration statement for the resale of underlying common stock, with effectiveness required within 90 days (or 120 days if fully reviewed).
  • Issuance Restrictions: The Company is restricted from issuing common stock or equivalents at a price below the Series F conversion price until December 31, 2023, without purchaser consent.

Guidance, Outlook, and Risks

Management Commentary: The filing focuses on the execution of the financing agreement and the legal terms of the new security class. No forward-looking guidance or operational outlook is provided in this document.

Risks and Contingencies:

  • Dilution: Future conversion of preferred stock will increase the number of outstanding common shares.
  • Issuance Constraints: The "no-shop" provision regarding pricing until December 31, 2023, may limit the Company's ability to raise additional equity at lower valuations.
  • Regulatory Timing: The Company faces a deadline to declare the registration statement effective within 90 to 120 days.

Investor Verification Checklist

  • Verify the exact number of common shares currently outstanding to calculate the potential dilution impact of the 19.99% beneficial ownership limit.
  • Review the attached Certificate of Designation (Exhibit 3.1) for specific anti-dilution adjustment mechanisms.
  • Confirm the status of the registration statement filing required under the Registration Rights Agreement.
  • Assess the impact of the issuance restriction on the Company's ability to raise further capital before December 31, 2023.